SCHEMBL13170368

SCHEMBL13170368

CC(=O)[C@H]1CN(CC(=O)[C@H]2CN(C)[C@@H](C)C(=O)N2)[C@@H](C)C(=O)N1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13435404 0.85 TSHR (0.30) —
SCHEMBL12572203 0.85 TSHR (0.30) —
SCHEMBL13170323 0.85 TSHR (0.30) —
SCHEMBL13170363 0.85 TSHR (0.30) —
SCHEMBL13170358 0.72 TSHR (0.34) —
SCHEMBL12572123 0.72 TSHR (0.34) —
SCHEMBL13435402 0.70 TSHR (0.53) —
SCHEMBL12572121 0.70 TSHR (0.53) —
SCHEMBL13170364 0.69 PRKCD (0.31) —
SCHEMBL12572195 0.69 TSHR (0.38) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7795221-B2 Linear natriuretic peptide constructs PALATIN TECHNOLOGIES, INC. (US) 2010-09-14 — — US disclosed
US-20070232546-A1 Linear Natriuretic Peptide Constructs PALATIN TECHNOLOGIES, INC. (US) 2007-10-04 — — US disclosed
Send feedback